# Liquet Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/liquet-medical

- Industry: Medical Devices & Equipment
- Headquarters: Glen Allen, US
- Website: www.liquetmedical.com
- Latest round: Seed (Jun 25, 2025)
- Investors on record: 1

## About

Liquet Medical Inc. is a US-based company specializing in advanced medical technologies, focusing on the development and commercialization of innovative devices for targeted drug delivery in vascular treatments.Liquet Medical Inc. was founded in 2020 and is headquartered in Glen Allen, US. The company focuses on medical technologies, particularly the development of devices for vascular treatments. It has completed one investment deal, with the most recent occurring on June 25, 2025. The firm was established by entrepreneurs with a history in medical innovation, though specific details on their previous ventures are not provided.Liquet Medical Inc. specializes in advanced medical technologies, primarily focusing on the development and commercialization of the Versus™ Catheter, their flagship product. This innovative device is designed for the controlled and selective infusion of physician-specified fluids, including thrombolytics, directly into the pulmonary artery vasculature of adult patients. Additionally, it provides real-time pressure monitoring, allowing healthcare professionals to assess a patient’s hemodynamic condition accurately. The Versus™ Catheter is a patent-protected solution addressing critical needs in vascular disease treatment, aiming to enhance patient outcomes through localized drug delivery. The company serves a diverse client base, including healthcare institutions and specialized medical facilities across the United States and international markets, particularly in regions with a high prevalence of vascular diseases.The revenue model for Liquet Medical Inc. revolves around the sale of its Versus™ Catheter, marketed directly to healthcare providers and institutions. Transactions typically occur through direct sales, where hospitals and medical centers purchase the catheter and related services, establishing a B2B framework. This model involves both one-time purchases and recurring orders based on healthcare facilities' needs. The pricing structure for the Versus™ Catheter is strategically positioned to reflect its advanced technology and the critical role it plays in treatment outcomes.Liquet Medical Inc. plans to utilize its recent funding raised in June 2025 from Virginia Venture Partners to accelerate its clinical study and the delivery of its drug solutions to patients. The company is also working on upcoming new products related to targeted drug delivery, with specific release dates to be determined. Additionally, it aims to expand into new geographic regions, focusing on areas that have a high incidence of vascular diseases to enhance its market presence.

## Funding rounds

- Seed, Jun 25, 2025 — Virginia Venture Partners

## Investors

- Virginia Venture Partners (https://capitalatlas.ai/funds/virginia-venture-partners) — Seed